DA CONSULTING GROUP INC
DEFS14A, EX-1, 2000-09-11
BUSINESS SERVICES, NEC
Previous: DA CONSULTING GROUP INC, DEFS14A, 2000-09-11
Next: LINCOLN LIFE & ANNUITY FLEXIBLE PREM VARI LIFE ACCT M, N-30D, 2000-09-11



                                                                         ANNEX I

                          SECURITIES PURCHASE AGREEMENT


     This  SECURITIES  PURCHASE AGREEMENT (this "Agreement"), dated as of August
2,  2000  is  made by and between DA CONSULTING GROUP, INC., a Texas corporation
(the  "Company"),  and  the  investor  named  on  the signature page hereto (the
"Investor").

                                    RECITALS:

     A.     The  Company  desires to borrow, and the Investor desires to lend to
the  Company,  Two  Million ($2,000,000) as an unsecured loan upon the terms and
conditions  stated  in  this  Agreement.

     B.     The  Investor  desires  to purchase and the Company desires to sell,
upon  the  terms  and  conditions  stated  in  this  Agreement  (i)  Two Million
(2,000,000)  shares  of the Common Stock, (ii) a warrant to purchase Two Million
(2,000,000)  shares of Common Stock, and (iii) an additional warrant to purchase
One  Million  (1,000,000)  shares  of  Common  Stock.

     C.     The capitalized terms used herein and not otherwise defined have the
meanings  given  them  in  Article  X  hereof.

     In  consideration of the premises and the mutual covenants contained herein
and  other good and valuable consideration, the receipt and sufficiency of which
are  hereby  acknowledged, the Company and the Investor hereby agree as follows:

                                    ARTICLE I
                                      LOAN

     1.1     Loan.  Upon  execution  of this Agreement, subject to the terms and
             ----
conditions  hereof,  (i)  the  Investor  shall make a loan to the Company of Two
Million  Dollars  ($2,000,000)  (the  "Loan"),  by  wire transfer of immediately
available  funds  in  accordance  with  the  Company's written wire instructions
against delivery by the Company to the Investor of a Promissory Note in the form
of  Exhibit  A  (the  "Note").
    ----------

     1.2     Repayment  of  the  Loan.  The principal amount of, and all accrued
             ------------------------
interest  on,  the Loan shall be payable on the date (the "Maturity Date") which
is  (i) ninety (90) days after the date of the Note, or (ii) in the event that a
Special  Meeting is held prior to the expiration of such ninety (90) day period,
and (a) Shareholder Approval is obtained at such Special Meeting, on the earlier
to  occur  of the Closing Date and seven (7) days after the date of such Special
Meeting,  or  (b)  Shareholder Approval is not obtained at such Special Meeting,
then the Maturity Date shall be the date ninety (90) days after the date of such
Special  Meeting,  at  which  time  the  Company  shall transfer such sum to the
Investor  by  wire  transfer  of immediately available funds.  In the event that
Shareholder  Approval  is obtained, on the Closing Date the principal amount of,
and all accrued interest on, the Loan shall be applied to the Purchase Price (as
defined  in  Section  2.1)  without  set-off  or counterclaim.  In either event,
promptly  upon  payment  in  full, the Investor agrees to return the Note to the
Company,  marked  "cancelled".  As used herein, "Special Meeting" shall mean the
special  meeting  of  the  shareholders of the Company described in Section 5.12
hereof.

                                   ARTICLE II
                         PURCHASE AND SALE OF SECURITIES


                                      I - 1
<PAGE>
     2.1     Purchase  and  Sale  of Securities.  At the Closing, subject to the
             ----------------------------------
terms  of  this  Agreement  and the satisfaction or waiver of the conditions set
forth  in  Articles  VIII and IX hereof, the Company shall issue and sell to the
Investor,  and  the  Investor  shall purchase from the Company, for an aggregate
purchase  price of Four Million Eight Hundred Thousand Dollars ($4,800,000) (the
"Purchase  Price"):

          (a)     Two  Million  (2,000,000)  shares  of  the  Common  Stock (the
"Shares")  at  a  purchase  price  per  share  of  $2.40;

          (b)     A  warrant,  substantially  in  the  form  of  Exhibit  B (the
                                                                 ----------
"Initial  Warrant")  to  purchase  Two  Million (2,000,000) shares of the Common
Stock  (the  "Warrant  Shares")  at  an  exercise  price  per  share (subject to
adjustment  as  provided  therein)  equal  to the greater of (x) $3.00 or (y) an
amount  equal  to  eighty-five  percent (85%) multiplied by the Market Price Per
Share,  exercisable  for a period of three (3) years following the Closing Date;
and

          (c)     A warrant, substantially in the form of Exhibit C (the "Second
                                                          ---------
Warrant"  and  together  with  the  Initial  Warrant,  the  "Warrants", and each
individually  a  "Warrant")  to  purchase  One Million (1,000,000) shares of the
Common  Stock (the "Additional Warrant Shares") at an exercise price (subject to
adjustment as provided therein) equal to $3.00 per share, exercisable during the
period  beginning  January  2,  2002  and ending on the third anniversary of the
Closing  Date.  (The  Note, Shares, Warrant Shares and Additional Warrant Shares
shall  be  referred  to  collectively  herein  as  the  "Securities").

     Notwithstanding  anything herein to the contrary, the Investor shall not be
required to (but may, at its option) purchase more than such number of shares so
as  to  cause  Investor,  as  a  result  of  the  Closing,  to be subject to the
notification  and  report  requirements  under  the  Hart-Scott-Rodino Antitrust
Improvements  Act  of 1976 (the "HSR Act"); provided that, in no event shall the
foregoing  clause entitle the Investor to purchase fewer Shares than the maximum
number  of  Shares  that  may  be  purchased  without causing the Investor to be
subject  to  the  requirements  of  the  HSR  Act.

     2.2     Payment.  The  Investor  shall  pay  the  Purchase  Price  by  wire
             -------
transfer of immediately available funds in accordance with the Company's written
wire  instructions, upon delivery by the Company to the Investor of the Warrants
and  certificates  representing  the  Shares,  and the Company shall deliver the
Warrants  and  such  certificates  against  delivery  of  the  Purchase Price as
described  above;  provided,  however,  that  if  Shareholder Approval is timely
obtained  in  accordance  with  Section  1.2 hereof, the Company shall apply the
principal  of  and  accrued  interest  on the Loan to the Purchase Price without
setoff or counterclaim, and the excess of the Purchase Price over such principal
and  interest  shall  be  paid  by  the  Investor  to the Company in immediately
available  funds  at  the  Closing.

     2.3     Closing  Date.  Subject  to  the  satisfaction  or  waiver  of  the
             -------------
conditions  set  forth  in  Articles  VIII and IX hereof, the Closing shall take
place  at  12:00 noon central time on a date mutually agreed upon by the parties
which  shall  be  no  later  than  six  (6) days after the date that Shareholder
Approval  is  obtained  (the  "Closing Date").  The Closing shall be held at the
offices  of  the  Company,  or at such other place as the parties agree.  At the
Closing,  after  receipt  of  payment  therefor,  the  Company shall deliver the
Warrants to the Investor and the Company shall authorize its transfer agent (the
"Transfer  Agent")  to  arrange  delivery  to  the Investor of one or more stock
certificates representing the Shares, such Warrants and each such certificate to
be  registered  in  the  name  of  the Investor or, if so indicated on the Stock
Certificate Questionnaire attached hereto as Exhibit D, in the name of a nominee
                                             ---------
designated  by  the  Investor.


                                      I - 2
<PAGE>
                                   ARTICLE III
                    INVESTOR'S REPRESENTATIONS AND WARRANTIES

     The  Investor  represents  and  warrants  to  the  Company  that:

     3.1     Investment  Purpose.  The Investor is purchasing the Securities for
             -------------------
its  own  account  and  not  with  a  present  view  toward  the  public sale or
distribution  thereof,  except  pursuant  to  sales  registered or exempted from
registration  under  the  Securities  Act; provided, however, that by making the
representation herein, the Investor does not agree to hold any of the Securities
for  any minimum or other specific term and reserves the right to dispose of the
Securities  at  any  time  in  accordance  with  or  pursuant  to a registration
statement  or  an  exemption  under  the  Securities  Act.

     3.2     Accredited  Investor  Status.  The  Investor  is  an  "accredited
             ----------------------------
investor"  as  defined in Rule 501(a) of Regulation D and was not formed for the
specific  purpose  of  acquiring  the  Securities.

     3.3     Reliance  on  Exemptions.  The  Investor  understands  that  the
             ------------------------
Securities are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities
laws  and  that  the  Company is relying upon the truth and accuracy of, and the
Investor's  compliance  with,  the  representations,  warranties,  agreements,
acknowledgments  and understandings of the Investor set forth herein in order to
determine  the  availability  of  such  exemptions  and  the  eligibility of the
Investor  to  acquire  the  Securities.

     3.4     Information.  The  Investor  and  its  advisors,  if any, have been
             -----------
furnished  with  all materials relating to the business, finances and operations
of  the Company, and materials relating to the offer and sale of the Securities,
that  have been requested by the Investor or its advisors, if any.  The Investor
and its advisors, if any, have been afforded the opportunity to ask questions of
the  Company.  Neither  such inquiries nor any other due diligence investigation
conducted  by  the  Investor or any of its advisors or representatives modifies,
amends  or affects the Investor's right to rely on the Company's representations
and  warranties  contained  in  Article IV below.  The Investor acknowledges and
understands  that its investment in the Securities involves a significant degree
of risk.  The Investor acknowledges that, except as set forth herein, it has not
relied  on  any  materials  other  than  the  SEC  Documents  in  purchasing the
Securities.

     3.5     Governmental  Review.  The  Investor  understands  that  no  United
             --------------------
States  federal  or  state agency or any other government or governmental agency
has  passed  upon or made any recommendation or endorsement of the Securities or
an  investment  therein.

     3.6     Transfer  or  Resale.  The  Investor  understands  that:
             --------------------

          (a)     except as provided in Article VI, the Securities have not been
and are not required to be registered under the Securities Act or any applicable
state  securities laws and, consequently, the Investor may have to bear the risk
of owning the Securities for an indefinite period of time because the Securities
may  not  be  transferred  unless (i) the resale of the Securities is registered
pursuant  to  an effective registration statement under the Securities Act; (ii)
the  Investor  has  delivered  to  the  Company  an opinion of counsel (in form,
substance  and  scope  customary  for  opinions  of  counsel  in  comparable
transactions) to the effect that the Securities to be sold or transferred may be
sold  or  transferred pursuant to an exemption from such registration; (iii) the
Securities  are sold or transferred pursuant to Rule 144; or (iv) the Securities
are sold or transferred to an affiliate (as defined in Rule 144) of the Investor
pursuant  to  an  exemption  from  registration  under  the  Securities  Act;


                                      I - 3
<PAGE>
          (b)     any sale of the Securities made in reliance on Rule 144 may be
made  only  in  accordance  with  the  terms of Rule 144 and, if Rule 144 is not
applicable, any resale of the Securities under circumstances in which the seller
(or the person through whom the sale is made) may be deemed to be an underwriter
(as that term is defined in the Securities Act) may require compliance with some
other exemption under the Securities Act or the rules and regulations of the SEC
thereunder;  and

          (c)     except as set forth in Article VI, neither the Company nor any
other  person  is  under  any  obligation  to  register the Securities under the
Securities  Act  or  any  state  securities laws or to comply with the terms and
conditions  of  any  exemption  thereunder.

     3.7     Legends.  The  Investor understands that until such time as (a) the
             -------
Securities  may  be  sold by the Investor under Rule 144(k) or (b) the resale of
the  Securities  has been registered under the Securities Act as contemplated by
Article  VI,  the  certificates  representing  the  Securities  shall  bear  a
restrictive  legend  in  substantially  the  following form (and a stop-transfer
order  may  be placed against transfer of the certificates for such Securities):

     THE  SECURITIES  REPRESENTED  BY  THIS CERTIFICATE HAVE NOT BEEN REGISTERED
     UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY
     STATE OF THE UNITED STATES.  THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR
     ASSIGNED IN THE  ABSENCE  OF  AN  EFFECTIVE  REGISTRATION STATEMENT FOR THE
     SECURITIES  UNDER  APPLICABLE  SECURITIES  LAWS, OR UNLESS OFFERED, SOLD OR
     TRANSFERRED  PURSUANT  TO AN  AVAILABLE  EXEMPTION  FROM  THE  REGISTRATION
     REQUIREMENTS  OF  THOSE LAWS.

     The  legend  set forth above shall be removed and the Company shall issue a
certificate without the legend to the holder of any certificate upon which it is
stamped,  in  accordance  with  the  terms  of  Article  VI  hereof.

     3.8     Authorization;  Enforcement.  This  Agreement  has  been  duly  and
             ---------------------------
validly  authorized,  executed  and delivered on behalf of the Investor and is a
valid  and  binding agreement of the Investor enforceable in accordance with its
terms,  subject  to  the  effect  of  any  applicable  bankruptcy,  insolvency,
reorganization,  moratorium  or  similar  laws affecting the rights of creditors
generally  and  the  application  of  general  principles  of  equity.

     3.9     Residency.  The  Investor  is  not  a  U.S. Person (as that term is
             ---------
defined  in  Regulation  S under the Securities Act ("Regulation S")) and is not
acquiring  the  Securities  for  the account or benefit of any U.S. Person.  The
Investor  agrees  to  resell  the  Securities  only  (i)  in accordance with the
provisions  of  Regulation S, (ii) pursuant to registration under the Securities
Act,  or  (iii)  pursuant  to an available exemption from such registration; and
agrees  not  to  engage  in  hedging  transactions with regard to the Securities
unless  in  compliance  with  the Securities Act.  The Investor acknowledges and
understands that a legend will be placed on any certificates(s) representing the
Securities  stating  that transfer of the Securities is prohibited except (i) in
accordance  with  the  provisions of Regulation S, (ii) pursuant to registration
under  the  Securities  Act,  or  (iii)  pursuant to an available exemption from
registration;  and  that hedging transactions involving those securities may not
be  conducted  unless  in  compliance  with  the  Securities  Act.  The Investor
acknowledges  and agrees that unless applicable foreign law prevents the Company
from  refusing  to  register  securities  transfers,  the Company will refuse to
register  any  transfer  of  the  Securities not made (i) in accordance with the
provisions  of  Regulation S, (ii) pursuant to registration under the Securities
Act,  or  (iii)  pursuant  to  an  available  exemption  from such registration.


                                      I - 4
<PAGE>
     3.10     Organization.  The  Investor  is  duly organized, validly existing
              ------------
and  in  good  standing under the laws of the British Virgin Islands and has all
requisite  power  and authority to own and lease its properties, to carry on its
business  as  presently conducted and to carry out the transactions contemplated
hereby.

     3.11     No  Conflict.  The  execution  and delivery of this Agreement will
              ------------
not violate or be in conflict with any order, judgment, injunction, agreement or
controlling  document  to which the Investor is a party or by which it is bound.

     3.12     No  Ownership.  Neither the Investor nor any of its affiliates (as
              -------------
defined  in  Rule   12-b  under  the  Exchange  Act)  has  record  or beneficial
ownership  (as  defined  in  Rule 13d-3 under the Exchange Act) of any shares of
the  Company's  Common  Stock.

     3.13     Foreign  Requirements.  The  issuance  of  the  Securities  to the
              ---------------------
Investor,  to  the  extent  such issuance is governed by laws of a country other
than  the  United  States,  does  not  require any filing, registration or other
action  by the Company in accordance with the local laws and customary practices
and  documentation  of  such  country.

     3.14     Note.  The  Investor  acknowledges that treatment of the Note as a
              ----
security,  as  between the parties, does not constitute admission by the Company
that  the  Note  is  a  security  under  federal  and  state  security  laws.

                                   ARTICLE IV
                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     The Company represents, warrants and covenants to the Investor that, except
as  set  forth  in  the Disclosure Schedules attached hereto as Exhibit E (which
                                                                ---------
representations,  warranties  and  covenants  shall  be  deemed  to apply, where
appropriate,  to  each  subsidiary  of  the  Company):

     4.1     Organization  and Qualification.  The Company is duly incorporated,
             -------------------------------
validly existing and in good standing under the laws of the State of Texas, with
full  power  and  authority (corporate and other) to own, lease, use and operate
its  properties  and  to  carry  on its business as and where now owned, leased,
used,  operated and conducted.  The Company is duly qualified to do business and
is  in  good  standing in every jurisdiction in which the nature of the business
conducted  by it makes such qualification necessary, except where the failure to
be  so  qualified  or in good standing would not have a Material Adverse Effect,
and  to  the  Company's knowledge, no proceeding has been instituted in any such
jurisdiction  revoking,  limiting  or curtailing, or seeking to revoke, limit or
curtail,  such  power  and  authority  or  qualification.

     4.2     Authorization;  Enforcement.  (a)  The  Company  has  all requisite
             ---------------------------
corporate power and authority to enter into and to perform its obligations under
this  Agreement,  the  Note  and  the  Warrants,  to consummate the transactions
contemplated  hereby  and thereby and to issue the Securities in accordance with
the  terms  hereof  and  thereof; (b) the execution, delivery and performance of
this Agreement, the Note and the Warrants by the Company and the consummation by
it  of  the  transactions  contemplated hereby (including without limitation the
issuance  of the Securities) have been duly authorized by the Company's Board of
Directors,  and no further consent or authorization of the Company, its Board of


                                      I - 5
<PAGE>
Directors,  or  its  shareholders  is  required except as expressly contemplated
herein  with  respect  to the Closing; (c) this Agreement and the Note have been
duly  executed  by  the Company; and (d) this Agreement and the Note constitute,
and  when executed and delivered by the Company, the Warrants will constitute, a
legal,  valid  and  binding  obligation  of  the Company enforceable against the
Company  in accordance with their terms, subject to the effect of any applicable
bankruptcy,  insolvency, reorganization, or moratorium or similar laws affecting
the  rights  of creditors generally and the application of general principles of
equity.

     4.3     Capitalization.  The  authorized  capital  stock  of  the  Company
             --------------
consists  of (a) 40,000,000 shares of Common Stock, $.01 par value per share, of
which  6,418,604 shares were issued and outstanding as of July 31, 2000, and (b)
10,000,000  shares  of  preferred stock, $.01 par value per share, none of which
are  issued and outstanding.  All of the outstanding shares of capital stock are
duly  authorized,  validly  issued,  fully  paid and nonassessable and have been
issued  in  compliance with all federal and state securities laws.  No shares of
capital  stock  of  the  Company  are  subject to preemptive rights or any other
similar  rights  of the shareholders of the Company or any liens or encumbrances
imposed  through  the  actions or failure to act of the Company.  Except for the
transactions  contemplated  hereby,  (i)  there  are  no  outstanding  options,
warrants,  scrip, rights to subscribe for, puts, calls, rights of first refusal,
agreements,  understandings,  claims  or  other  commitments  or  rights  of any
character  whatsoever  relating  to,  or  securities or rights convertible into,
exercisable for, or exchangeable for any shares of capital stock of the Company,
or  arrangements by which the Company is or may become bound to issue additional
shares  of  capital  stock  of  the  Company;  (ii)  there  are no agreements or
arrangements (other than this Agreement) under which the Company is obligated to
register  the  sale of any of its securities under the Securities Act; and (iii)
there  are  no  anti-dilution  or  price  adjustment provisions contained in any
security issued by the Company (or in any agreement providing rights to security
holders)  that will be triggered by the issuance of the Securities. There are no
stockholder  agreements,  voting  agreements  or  other  similar agreements with
respect  to  the  Common Stock to which the Company is a party.  The Company has
made  available  to  the  Investor, if requested, true and correct copies of the
Company's  Certificate  of  Incorporation,  as amended, as in effect on the date
hereof,  the  Company's By-laws as in effect on the date hereof and the terms of
all  securities  convertible into or exercisable for Common Stock of the Company
and  the  material  rights  of  the  holders  thereof  in  respect  thereto.

     4.4     Issuance  of  Securities.  Each  of  the  Shares, the Warrants, the
             ------------------------
Warrant  Shares, and the Additional Warrant Shares are duly authorized and, upon
issuance  in  accordance  with  the  terms of this Agreement or the Warrants, as
applicable,  the  Securities (other than the Note) will be validly issued, fully
paid  and  nonassessable,  free  from all taxes, liens, claims, encumbrances and
charges  with  respect  to  the issue thereof, will not be subject to preemptive
rights  or  other  similar  rights  of shareholders of the Company, and will not
impose  personal  liability  on  the  holders  thereof.  No  further approval or
authority  of  the  shareholders  or  the  Board  of Directors of the Company is
required for the issuance of the Note, and, except for the Shareholder Approval,
for  the issuance and sale of the Securities (other than the Note) to be sold by
the  Company  as contemplated in this Agreement and the Warrants. Subject to the
accuracy  of the Investor' representations and warranties in Article III of this
Agreement,  the  offer,  sale, and issuance of the Securities in conformity with
the terms of this Agreement constitute transactions exempt from the registration
requirements  of  Section  5  of the Securities Act and from the registration or
qualification  requirements of the laws of any applicable state or United States
jurisdiction.

     4.5     No  Conflicts;  No  Violation.
             -----------------------------


                                      I - 6
<PAGE>
          (a)     The execution and delivery of this Agreement and the Note, the
execution  and  delivery  by  the  Company  of  the  Warrants to be executed and
delivered by the Company, the performance of this Agreement and the Note and the
Warrants  and  the  consummation by the Company of the transactions contemplated
hereby  and  thereby  (including,  without  limitation,  the  issuance  of  the
Securities  and  the  Warrants),  will  not  (i)  conflict  with  or result in a
violation  of  any provision of its Certificate of Incorporation, as amended, or
By-laws,  as amended, or (ii) violate or conflict with, or result in a breach of
any  provision  of,  or  constitute  a default (or an event which with notice or
lapse  of  time  or  both  could  become a default) under, or give to others any
rights of termination, amendment (including without limitation the triggering of
any  anti-dilution  provision),  acceleration or cancellation of, any agreement,
indenture,  patent,  patent  license,  or  instrument  to which the Company is a
party,  or  (iii)  result  in  a  violation of any law, rule, regulation, order,
judgment  or  decree  (including  U.S.  federal  and  state  securities laws and
regulations  and  regulations  of any self-regulatory organizations to which the
Company or its securities are subject) applicable to the Company or by which any
property  or  asset  of  the  Company  is  bound  or  affected  (except for such
conflicts,  breaches,  defaults,  terminations,  amendments,  accelerations,
cancellations  and  violations  as  would not, individually or in the aggregate,
have  a  Material  Adverse  Effect  and  except  to  the extent that Shareholder
Approval is required for the issuance and sale of the Securities (other than the
Note).

          (b)     The  Company  is  not  in  violation  of  its  Certificate  of
Incorporation,  as  amended,  or  By-laws, as amended, and the Company is not in
default  (and  no  event has occurred which with notice or lapse of time or both
could  put  the Company in default) under any agreement, indenture or instrument
to  which  the  Company  is  a  party  or by which any property or assets of the
Company  are  bound or affected, except for such possible defaults as would not,
individually  or  in  the  aggregate,  have  a  Material  Adverse  Effect.

          (c)     The Company is not conducting its business in violation of any
law,  ordinance  or regulation of any governmental entity, the failure to comply
with  which  would,  individually  or  in the aggregate, have a Material Adverse
Effect.

          (d)     Except  as  specifically contemplated by this Agreement and as
required  under  the  Securities Act and any applicable state securities laws or
any  listing  agreement  with  any  securities  exchange  or automated quotation
system,  the  Company  is  not  required to obtain any consent, authorization or
order  of,  or  make  any filing or registration with, any court or governmental
agency  or  any regulatory or self-regulatory agency in order for it to execute,
deliver  or  perform  any  of its obligations under this Agreement in accordance
with  the  terms  hereof, or to issue and sell the Securities in accordance with
the terms hereof.  In the case of the issuance and sale of the Securities (other
than  the  Note), except for Shareholder Approval, all consents, authorizations,
orders,  filings  and  registrations  which  the  Company  is required to obtain
pursuant to the preceding sentence have been obtained or effected on or prior to
the  date  hereof.

     4.6     SEC  Documents,  Financial  Statements.  Since  June  30, 1999, the
             --------------------------------------
Company  has  timely  filed  all reports, schedules, forms, statements and other
documents  required  to  be  filed  by it with the SEC pursuant to the reporting
requirements  of  the Exchange Act (all of the foregoing filed prior to the date
hereof  and all exhibits included therein and financial statements and schedules
thereto  and  documents (other than exhibits) incorporated by reference therein,
being  hereinafter  referred  to  as  the  "SEC  Documents").  The  Company  has
delivered  to the Investor, or the Investor has had access to, true and complete
copies  of  the  SEC  Documents,  except  for  such  exhibits  and  incorporated
documents.  As  of  their  respective  dates,  the SEC Documents complied in all
material  respects  with  the requirements of the Exchange Act or the Securities
Act,  as  the  case may be, and the rules and regulations of the SEC promulgated


                                      I - 7
<PAGE>
thereunder  applicable  to  the SEC Documents, and none of the SEC Documents, at
the  time  they  were  filed  with  the SEC, contained any untrue statement of a
material  fact or omitted to state a material fact required to be stated therein
or  necessary  in  order  to  make  the  statements  therein,  in  light  of the
circumstances  under  which  they  were  made,  not  misleading.  As  of  their
respective  dates, the consolidated financial statements of the Company included
in  the  SEC  Documents  complied  as  to  form  in  all  material respects with
applicable  accounting  requirements  and the published rules and regulations of
the  SEC  with respect thereto.  Such financial statements have been prepared in
accordance  with  U.S.  generally  accepted  accounting principles, consistently
applied,  during  the periods involved (except (a) as may be otherwise indicated
in  such  financial  statements  or  the  notes  thereto,  or (b) in the case of
unaudited  interim  consolidated  statements, to the extent they may not include
footnotes  or  may be condensed or summary statements) and fairly present in all
material  respects  the consolidated financial position of the Company as of the
dates  thereof and the consolidated results of its operations and cash flows for
the  periods then ended (subject, in the case of unaudited statements, to normal
year-end  audit  adjustments).  Except  as set forth in the financial statements
included  in  the  SEC  Documents, the Company has no liabilities, contingent or
otherwise,  other  than  (x)  liabilities  incurred  in  the  ordinary course of
business subsequent to the date of such financial statements, (y) liabilities of
the  type  not  required  under  generally  accepted accounting principles to be
reflected  in such financial statements, and (z) obligations under contracts and
commitments  not  required  under generally accepted accounting principles to be
reflected  in such financial statements.  Such liabilities and obligations would
not,  individually  or  in  the  aggregate,  have  a  Material  Adverse  Effect.

     4.7     Absence  of  Certain  Changes.  Since March 31, 2000, there has not
             -----------------------------
been (a) any material adverse change in or affecting the condition, financial or
otherwise,  or  in the earnings or assets of the Company, whether or not arising
in  the  ordinary  course  of  business, except for net losses of the Company as
previously  disclosed  to the Investor; (b) any transactions entered into by the
Company, other than those in the ordinary course of business, which are material
with  respect  to  the  Company;  (c)  any  dividend or distribution of any kind
declared,  paid  or made on the capital stock of the Company; or (d) any loss or
damage  (whether  or  not  insured)  to  the  physical property or assets of the
Company  which  has  a  Material  Adverse  Effect.

     4.8     Absence  of  Litigation.  There  is  no  action,  suit,  claim,
             -----------------------
proceeding,  inquiry  or  investigation  before  or  by any court, public board,
government  agency,  self-regulatory  organization  or  body  pending or, to the
knowledge  of the Company, threatened against or affecting the Company or any of
its  officers  or  directors  acting  as such that would, individually or in the
aggregate,  have  a  Material  Adverse  Effect,  or  which  would materially and
adversely  affect  the  consummation  of  this  Agreement. The Company is not in
default  with  respect  to  any  judgment,  order  or  decree  of  any  court or
governmental  agency or instrumentality which, singly or in the aggregate, would
have  a  Material  Adverse  Effect.

     4.9     NASDAQ  Compliance.  The  Company's  Common  Stock  is  registered
             ------------------
pursuant  to  Section  12(g)  of  the  Exchange  Act and is listed on The Nasdaq
National Market (the "Nasdaq Stock Market"), and the Company has taken no action
designed  to  terminate  the registration of the Common Stock under the Exchange
Act  or delisting the Common Stock from the Nasdaq Stock Market.  The Company is
not  aware  of,  and  has  not received any notice of, any efforts or actions to
terminate  the registration of the Common Stock under the Exchange Act or delist
the  Common  Stock  from  the  Nasdaq  Stock  Market.  The Company shall use its
commercially  reasonable efforts to comply with all requirements of the National
Association  of  Securities  Dealers,  Inc.  with respect to the issuance of the
Securities  and  the  listing  thereof  on  the Nasdaq Stock Market at all times
during  the  period  beginning  on the date hereof and ending two years from the
date  of  effectiveness  of  the  Registration  Statement.


                                      I - 8
<PAGE>
     4.10     No  Manipulation  of  Stock.  The  Company has not taken and shall
              ---------------------------
not, in violation of applicable law, take any action outside the ordinary course
of  business that is designed to, or that might reasonably be expected to, cause
or  result  in  unlawful  manipulation  of  the  price  of  the  Common Stock to
facilitate  the  sale  or  resale  of  the  Securities.

     4.11     Transfer  Taxes.  On  the Closing Date and on the date the Warrant
              ---------------
Shares and the Additional Warrant Shares are issued, all stock transfer or other
taxes (other than income taxes) which are required to be paid in connection with
the  sale  and  transfer to the Investor of the Securities will be, or will have
been,  fully  paid  or  provided  for  by  the  Company.

     4.12     No  Integrated Offering.  All offers and sales of capital stock of
              -----------------------
the  Company  before  the date of this Agreement were at all relevant times duly
registered  under or exempt from the registration requirements of the Securities
Act  and  were  duly  registered  or  subject to an available exemption from the
registration  requirements  of the applicable state securities or Blue Sky laws.
Neither  the Company, nor any of its affiliates, nor any person acting on its or
their  behalf,  has  directly  or  indirectly  made  any  offers or sales in any
security  or  solicited  any offers to buy any security under circumstances that
would  require  registration  under  the  Securities  Act of the issuance of the
Securities to the Investor.  The issuance of the Securities to the Investor will
not  be  integrated  with  any other issuance of the Company's securities (past,
current or future) for purposes of the Securities Act or any applicable rules of
Nasdaq.

     4.13     No Brokers.  The Company has taken no action which would give rise
              ----------
to  any  claim by any person for brokerage commissions, finder's fees or similar
payments  relating  to  this  Agreement or the transactions contemplated hereby.

     4.14     Investment  Company  Status.  The  Company  is  not  and  upon
              ---------------------------
consummation  of the sale of the Securities will not be an "investment company,"
a company controlled by an "investment company" or an "affiliated person" of, or
"promoter" or "principal underwriter" for, an "investment company" as such terms
are  defined  in  the  Investment  Company  Act  of  1940,  as  amended.

     4.15     Legal  Opinion.  The  Company  shall  cause to be delivered to the
              --------------
Investor  by  counsel  to  the  Company  a legal opinion in the form attached as
Exhibit  F  pertaining to, among other matters, the availability of an exemption
----------
from  the  registration  provisions  of  the  Securities  Act.

     4.16     Offering Materials.  Other than the SEC Documents, the Company has
              ------------------
not  distributed and shall not distribute prior to the Closing Date any offering
material  in  connection  with  the offering and sale of the Securities, and the
Investor acknowledges that it has not relied on any materials other than the SEC
Documents.  The  Company  has  not taken in the past nor shall it hereafter take
any  action  to  sell, offer for sale or solicit offers to buy any securities of
the  Company which would bring the offer, issuance or sale of the Securities, as
contemplated  by  this  Agreement,  within  the  provisions  of Section 5 of the
Securities  Act,  unless such offer, issuance or sale was or shall be within the
exemptions  of  Section  4  of  the  Securities  Act.

                                    ARTICLE V
                                    COVENANTS


                                      I - 9
<PAGE>
     5.1     Best  Efforts.  Each party shall use its best efforts to satisfy in
             -------------
a  timely  fashion  each  of the conditions to be satisfied by it under Articles
VIII  and  IX  of  this  Agreement.

     5.2     Form  D.  The Company shall file on a timely basis a Notice of Sale
             -------
of  Securities  on  Form  D  with  respect  to the Securities, as required under
Regulation  D,  and  shall provide a copy thereof to the Investor promptly after
such  filing.

     5.3     Securities  Laws  Compliance.  From  and  after  the  Closing,  the
             ----------------------------
Company  and  the Investor shall each comply with all applicable laws related to
any  Registration  Statement  relating  to the sale of the Securities and to the
offering and sale of securities and with all applicable rules and regulations of
governmental authorities in connection therewith (including, without limitation,
the  Securities  Act, the Exchange Act and the rules and regulations promulgated
by  the  SEC).

     5.4     Reporting  Status;  Eligibility  to  Use  Form  S-3.  The Company's
             ---------------------------------------------------
Common  Stock  is  registered  under Section 12 of the Exchange Act. The Company
shall  file  with the SEC a Current Report on Form 8-K disclosing this Agreement
and the transactions contemplated hereby within ten (10) business days after the
date hereof.  The Company currently meets, and shall use commercially reasonable
efforts to continue to meet, the "registrant eligibility" requirements set forth
in  the  general  instructions  to  Form  S-3.

     5.5     Expenses.  Each  of the Company and the Investor is liable for, and
             --------
shall  pay,  its  own  expenses  incurred  in  connection  with the negotiation,
preparation,  execution  and delivery of this Agreement and the other agreements
to be executed in connection herewith, including, without limitation, attorneys'
and  consultants'  fees  and  expenses.

     5.6     Financial  Information.  From  and  after  the Closing, the Company
             ----------------------
agrees  to send to the Investor those reports that it generally sends to holders
of  its  Common Stock, until the Investor transfers, assigns or sells all of its
Securities.

     5.7     Listing.  On  or before the twentieth (20th) business day following
             -------
the  Closing  Date, the Company shall use its commercially reasonable efforts to
secure  the  listing  of the Shares, and shall on or before the twentieth (20th)
business day following the exercise of each Warrant, use commercially reasonable
efforts  to  secure  the  listing  of  the Warrant Shares, or Additional Warrant
Shares  as  the case may be, upon each national securities exchange or automated
quotation  system,  if  any,  upon  which shares of Common Stock are then listed
(subject  to  official notice of issuance) and, so long as any Investor owns any
of  the  Securities,  shall  use its commercially reasonable efforts to maintain
such  listing  of  the  Securities.  The  Company  shall  use  its  commercially
reasonable  efforts  to  obtain  and,  so  long  as any Investor owns any of the
Securities,  maintain  the listing and trading of its Common Stock on Nasdaq, or
the  American  Stock  Exchange or the New York Stock Exchange, and shall use its
commercially  reasonable  efforts  to  comply in all respects with the Company's
reporting,  filing  and  other  obligations  under  the  bylaws  or rules of the
National  Association  of  Securities  Dealers,  Inc.  and  such  exchanges,  as
applicable.

     5.8     No  Integration.  The Company shall not make any offers or sales of
             ---------------
any  security  (other  than the Securities) under circumstances that would cause
the  offering  of  the  Securities  to  be integrated with any other offering of
securities  by  the  Company  (a)  for  the  purpose of any stockholder approval
provision applicable to the Company or its securities or (b) for purposes of any
registration  requirement  under  the  Securities  Act.


                                      I - 10
<PAGE>
     5.9     Due  Diligence;  Confidentiality.
             --------------------------------

          (a)     Prior  to  the date hereof, the Company has made available for
inspection  by  the  Investor  and its counsel (collectively, the "Inspectors"),
such  pertinent  financial  and other records, pertinent corporate documents and
properties  of  the  Company  (collectively,  the  "Records"),  as the Inspector
reasonably deems necessary to enable the Inspector to exercise its due diligence
responsibility.

          (b)     Each  Inspector  shall  hold in confidence, and shall not make
any  disclosure  (except  to  the Investor) of, any Records or other information
that  the  Company  determines  in  good  faith to be confidential, and of which
determination  the Inspectors are so notified, unless (i) the disclosure of such
Records  is  necessary  to  avoid  or  correct a misstatement or omission in any
Registration  Statement, (ii) the release of such Records is ordered pursuant to
a  subpoena  or  other  order  from  a  court  or  government  body of competent
jurisdiction,  or  (iii) the information in such Records has been made generally
available  to  the  public  other than by disclosure in violation of this or any
other  agreement.  The  Company  is  not  required  to disclose any confidential
information  in the Records to any Inspector unless and until such Inspector has
entered  into a confidentiality agreement (in form and substance satisfactory to
the Company) with the Company with respect thereto, substantially in the form of
this  Section 5.9.  The Investor shall, upon learning that disclosure of Records
containing  confidential  information  is  (x)  necessary  to avoid or correct a
material  misstatement  or material omission with respect to the Investor in any
Registration  Statement,  or (y) sought in or by a court or governmental body of
competent jurisdiction or through other means, give prompt notice to the Company
and allow the Company, at the Company's expense, to undertake appropriate action
to  prevent  disclosure  of,  or  to  obtain a protective order for, the Records
deemed  confidential.  Nothing  herein  shall  be deemed to limit the Investor's
ability  to  sell  Securities  in  a  manner  that  is otherwise consistent with
applicable  laws  and  regulations.

          (c)     The  Company  shall hold in confidence, and shall not make any
disclosure of, information concerning the Investor provided to the Company under
this  Agreement unless (i) disclosure of such information is necessary to comply
with  federal  or state securities laws, (ii) the disclosure of such information
is  necessary to avoid or correct a misstatement or omission in any Registration
Statement,  (iii)  the  release  of  such  information  is ordered pursuant to a
subpoena  or  other  order  from  a  court  or  governmental  body  of competent
jurisdiction,  (iv)  such  information  has been made generally available to the
public  other  than  by  disclosure  in violation of this Agreement or any other
agreement,  or  (v)  the  Investor  consents to the form and content of any such
disclosure.  If  the  Company  learns  that  disclosure  of  such  information
concerning  the  Investor  is  sought  in  or by a court or governmental body of
competent  jurisdiction  or  through  other means, the Company shall give prompt
notice  to  the Investor prior to making such disclosure and allow the Investor,
at  its expense, to undertake appropriate action to prevent disclosure of, or to
obtain  a  protective  order  for,  such  information.

     5.10     Board  of  Directors.
              --------------------

          (a)     From  and  after  the  date  that  the Shareholder Approval is
obtained, the Company agrees that, (A) the Company shall take appropriate action
to  cause  to be elected to the Board of Directors no more than one (1) director
designated by the Investor; and (B) thereafter for so long as the Investor shall
hold at least twenty-five percent (25%) of the Shares, at each annual meeting of
the shareholders of the Company, and at each special meeting of the shareholders
of  the Company called for the purpose of electing directors of the Company, and
at  any  time  at  which shareholders of the Company shall have the right to, or
shall,  vote for directors of the Company, then, in each such event, the Company
shall  nominate  for  election  to  the  Board  of  Directors  one  (1) director
designated  by  the  Investor.


                                     I - 11
<PAGE>
          (b)     For so long as the Note remains unpaid, or until the date that
the  Company  nominates  for election to the Board of Directors one (1) director
designated  by  the  Investor  as  described  in Section 5.10(a), if Shareholder
Approval  is  obtained,  the  Investor  shall  have the right to have one person
attend  all  meetings  of  the Company's Board of Directors as an observer.  The
Company  shall  provide  each  such  person with all information provided to its
Board  of  Directors,  provided such person agrees: (A) to keep such information
confidential and return same to the Company upon the request of the Company; (B)
to  be  subject to the same insider trading policies and restrictions as members
of  the Board of Directors; and (C) that such person shall have no right to vote
on  any  matter  that  comes  before  the  Company's  Board  of  Directors.

     5.11     Right  of  First  Offer.
              -----------------------

          (a)     The  Company  hereby grants to the Investor the right (but not
the  obligation)  to purchase any New Securities (as hereinafter defined), which
the  Company  may  propose  to  sell  and issue privately during the period (the
"Offering  Period")  of  180 days after the Closing; provided, however, that the
                                                     --------  -------
aggregate  purchase  price  of  New Securities which the Investor shall have the
right  to  purchase  pursuant  to this Section 5.11 shall not exceed $5,000,000.
For purposes of this Section 5.11, "New Securities" shall mean any Common Stock,
and  rights,  options  or  warrants to purchase such Common Stock, but shall not
include  shares  of  Common  Stock  issued or issuable to officers, directors or
employees of the Company pursuant to, or issued or issuable upon the exercise of
options granted to such persons (regardless of whether such options were granted
before  or  after  the  date of this Agreement) under, any stock option or other
equity  incentive  plan  approved  by  the  Board  of  Directors.

          (b)     If at any time the Company shall propose to sell and issue New
Securities privately during the Offering Period, it shall deliver written notice
to  the  Investor of its proposal.  If the Investor shall desire to purchase all
of  the New Securities, it shall, no later than ten (10) business days after its
receipt  of  the  above-described notice from the Company, notify the Company of
its  desire  to  purchase  the  New  Securities and specify the price, terms and
conditions  upon which the Investor desires to purchase the New Securities.  The
Investor's  offer  to purchase the New Securities shall by its terms remain open
and  irrevocable  for a period of ten (10) business days from the date notice of
such  offer  is  given.

          (c)     In  the  event  that  the Company shall decide not to sell and
issue  the  New  Securities  to  the  Investor,  the  Company shall not sell New
Securities  to  any  third  party  during the Offering Period on any other terms
without  first  having  provided  such purchase opportunity to the Investor with
respect  to  such  other  terms.

          (d)     Notwithstanding  anything  to  the  contrary  herein,  the
Investor's  right to purchase New Securities pursuant to this Section 5.11 shall
be  null  and  void if Nasdaq's Stock Market Marketplace Rules would require the
Company  to  obtain shareholder approval for the issuance of such New Securities
to  the  Investor.

     5.12     Shareholder  Meeting.  The  Company  shall use its best efforts to
              --------------------
hold a Special Meeting as soon as practicable for the sole purpose of obtaining,
in order to satisfy Nasdaq's rules relating to obtaining shareholder approval of
a  "change  of  control,"  the  approval of its shareholders with respect to the
transactions  contemplated  by  this  Agreement,  including  (x)  the  Company's
issuance  of  the Shares, Warrants and the terms thereof, and the Warrant Shares
and  the  Additional  Warrant Shares, and (y) the board representation rights of
the  Investor  set  forth  in  Section 5.10 hereof (the "Shareholder Approval").


                                     I - 12
<PAGE>
     5.13     Opinion.  The  Company  shall  cause  the  Investor  to receive an
              -------
opinion  letter  of  the Company's counsel, Pepper Hamilton LLP, dated as of the
Closing  Date  containing  opinions in substantially the form attached hereto as
Exhibit  F.
----------

     5.14     Transfer  Agent  Instructions.  The Company shall deliver evidence
              -----------------------------
reasonably  satisfactory  to  the Investor that the Company's transfer agent has
agreed  to  act in accordance with irrevocable instructions in the form attached
hereto  as  Exhibit  G.
            ----------

     5.15     HSR Act. In the event that the Investor elects to purchase Shares,
              -------
Warrant  Shares or Additional Warrant Shares, as the case may be, which purchase
would  cause  Investor to be subject to the notification and report requirements
of  the  HSR  Act,  the parties shall, prior to any such purchase, file with the
Federal  Trade  Commission  and  the Department of Justice the notifications and
reports  required  to  be  filed  pursuant  to  the  HSR  Act and shall file any
supplemental  information  which  may  be  reasonably  requested  in  connection
therewith,  which  notifications  and  reports  and  filing  of  supplemental
information  will  comply  in all material respects with the requirements of HSR
Act.  Each  party shall be responsible for the payment of one half of the filing
fees required to be made in connection with such notification.  Each party shall
furnish  to  the other party such information as such other party may reasonably
request  to assist it to make such filings as it may be legally required to make
under the HSR Act.  As promptly as practicable after the date of this Agreement,
the parties shall each further prepare and file all other filings required under
any  foreign,  federal,  state  or  local  laws  relating  to  the  transactions
contemplated  hereby  and  shall  promptly respond to any request for additional
information  with  respect  thereof.

                                   ARTICLE VI
                         REGISTRATION OF THE SECURITIES

     For  the  purpose of Articles VI and VII, the term "Registrable Securities"
shall  include  (i)  the  Shares,  (ii) the Warrant Shares, (iii) the Additional
Warrant Shares and (iv) any shares of capital stock issued or issuable from time
to  time (with any adjustments) in exchange for or otherwise with respect to the
Shares,  Warrant  Shares  or  Additional  Warrant  Shares.

     6.1     Registration  Procedures.  The  Company  shall:
             ------------------------

          (a)     Subject to receipt of necessary information from the Investor,
prepare and file with the SEC, no later than one (1) year after the Closing Date
(the  "Anniversary  Date"),  a  registration  statement  on  Form  S-3  (the
"Registration  Statement") to enable the resale of the Registrable Securities by
the  Investor  from  time  to time through the automated quotation system of the
Nasdaq  Stock  Market  (or the facilities of any national securities exchange on
which  the  Company's  Common  Stock  is then traded) or in privately-negotiated
transactions  (if Form S-3 is not available at that time, then the Company shall
file  a  Registration  Statement  on  such form as is then available to effect a
registration  of  the  Registrable  Securities  then outstanding, subject to the
consent of the Investor, which consent shall not be unreasonably withheld).  The
Company  shall  not, and shall not agree to, allow the holders of any securities
of  the Company to include any of their securities in any Registration Statement
under  this  Section  6.1  without  the  consent of the holders of a majority in
interest of the Registrable Securities then outstanding.  In addition, beginning


                                     I - 13
<PAGE>
six  (6) months after the Closing Date, the Company shall not register, or agree
to  register,  any  of  its securities for its own account or for the account of
shareholders  other  than  the  holders  of  the  Registrable  Securities  then
outstanding, without the consent of the holders of a majority in interest of the
Registrable  Securities  then outstanding, until the Registration Statement with
respect  to  such  has  been  declared  effective.

          (b)     Use its commercially reasonable efforts, subject to receipt of
necessary  information from the Investor, to cause the Registration Statement to
be  declared  effective  by  the  SEC  as  soon as practicable after filing. The
Company's  commercially reasonable efforts shall include, but not be limited to,
promptly  responding to all comments received from the staff of the SEC.  If the
Company receives notification from the SEC that the Registration Statement shall
receive no action or review from the SEC, then the Company shall, subject to its
rights  under  Section 6.2, cause the Registration Statement to become effective
within  five  (5)  business  days  after  such  SEC  notification.

          (c)     Use  its  commercially  reasonable efforts to prepare and file
with  the  SEC such amendments and supplements to the Registration Statement and
the  Prospectus  used  in  connection  therewith as may be necessary to keep the
Registration  Statement  current  and effective for a period not exceeding, with
respect  to  the  Registrable  Securities,  the  earliest  of  (i)  the  second
anniversary  of  the  date  of  effectiveness of the Registration Statement with
respect  to  the Registrable Securities, (ii) the date on which the Investor may
sell  all Registrable Securities then held by the Investor, without registration
or  without  regard  to  any  volume limitations by reason of Rule 144(k) of the
Securities Act or (iii) such time as all Registrable Securities purchased by the
Investor  in  this  Offering have been sold pursuant to a Registration Statement
(the  "Registration  Period").

          (d)     Furnish  to  the  Investor  whose  Registrable  Securities are
included  in  a  Registration  Statement, and to its legal counsel, (i) promptly
after  each document is prepared and publicly distributed, filed with the SEC or
received  by  the Company, one copy of any Registration Statement filed pursuant
to  this  Agreement  and any amendments thereto, each Preliminary Prospectus and
final  Prospectus  and  each  amendment  or  supplement thereto; and each letter
written  by  or  on  behalf  of  the  Company  to  the  SEC  and  each  item  of
correspondence  from  the  SEC or the staff of the SEC, in each case relating to
such  Registration  Statement  (other than any portion of any item thereof which
contains  information  for which the Company has sought confidential treatment);
and  (ii)  such number of copies of the Registration Statement, Prospectuses and
Preliminary  Prospectuses  in conformity with the requirements of the Securities
Act and such other documents as the Investor may reasonably request, in order to
facilitate the public sale or other disposition of all or any of the Registrable
Securities  by  the  Investor,  provided,  however,  that  the obligation of the
Company  to  deliver  copies  of Prospectuses or Preliminary Prospectuses to the
Investor shall be subject to the receipt by the Company of reasonable assurances
from  the Investor that the Investor shall comply with the applicable provisions
of  the  Securities  Act and of such other securities or Blue Sky laws as may be
applicable  in  connection  with  any  use  of  such Prospectuses or Preliminary
Prospectuses.  The  Company  shall  immediately notify by facsimile the Investor
whose  Registrable  Securities are included in any Registration Statement of the
effectiveness  of  the  Registration Statement and any post-effective amendment.

          (e)     Use  its  commercially  reasonable efforts to (i) register and
qualify  the  Registrable  Securities  covered by a Registration Statement under
such other securities or Blue Sky laws of such jurisdictions as the Investor who
holds (or has the right to hold) Registrable Securities being offered reasonably
requests, (ii) prepare and file in those jurisdictions any amendments (including
post-effective  amendments)  and  supplements  to  such  registrations  and
qualifications  as  may  be necessary to maintain their effectiveness during the


                                     I - 14
<PAGE>
Registration  Period,  (iii)  take  any other actions necessary to maintain such
registrations  and qualifications in effect at all times during the Registration
Period,  and  (iv)  take  any other actions reasonably necessary or advisable to
qualify  the  Registrable  Securities  for  sale  in  such  jurisdictions.
Notwithstanding  the  foregoing, the Company is not required, in connection with
such  obligations,  to  (A)  qualify to do business in any jurisdiction where it
would not otherwise be required to qualify but for this Section 6.1, (B) subject
itself  to general taxation in any such jurisdiction, (C) file a general consent
to  service  of  process  in any such jurisdiction, (D) provide any undertakings
that  cause material expense or burden to the Company, or (E) make any change in
its  Certificate  of  Incorporation  or By-laws, which in each case the Board of
Directors  of the Company determines to be contrary to the best interests of the
Company  and  its  shareholders.

          (f)     During  the  period when copies of the Prospectus are required
to be delivered under the Securities Act or the Exchange Act, file all documents
required to be filed with the Commission pursuant to Section 13, 14 or 15 of the
Exchange  Act within the time periods required by the Exchange Act and the rules
and  regulations  promulgated  thereunder.

          (g)     Advise the Investor, promptly after it shall receive notice or
obtain  knowledge  of  the  issuance  of  any  stop order by the SEC delaying or
suspending  the effectiveness of the Registration Statement or of the initiation
of  any  proceeding for that purpose; and it shall promptly use its commercially
reasonable  efforts  to  prevent the issuance of any stop order or to obtain its
withdrawal  at the earliest possible moment if such stop order should be issued.

     It shall be a condition precedent to the obligations of the Company to take
any  action pursuant to this Section 6.1, that the Investor shall furnish to the
Company such information regarding itself, the Registrable Securities to be sold
by  the  Investor,  and  the  intended method of disposition of such Registrable
Securities  as  shall  be required to effect the registration of the Registrable
Securities.

     The  Company  understands that the Investor disclaims being an underwriter,
but  the  Investor  being deemed an underwriter by the SEC shall not relieve the
Company  of  any  obligations  it  has hereunder, provided, however, that if the
Company  receives  notification  from  the  SEC  that  the Investor is deemed an
underwriter,  then  the  period  in  which the Company is obligated to submit an
acceleration  request  to  the  SEC  shall be extended to the earlier of (i) the
ninetieth  (90th)  day  after  such SEC notification, or (ii) one hundred twenty
(120)  days after the initial filing of the Registration Statement with the SEC.

     6.2     Transfer  of Registrable Securities After Registration; Suspension.
             ------------------------------------------------------------------
The  Investor agrees that it shall not effect any disposition of the Registrable
Securities  except  as contemplated in the Registration Statement referred to in
Section  6.1 or as otherwise permitted by law, and that it shall promptly notify
the  Company  of  any  changes  in the information set forth in the Registration
Statement  regarding  the  Investor  or  its  plan  of  distribution.

          (a)     Any  Registration  Statement  (including  any  amendments  or
supplements  thereto  and  Prospectuses  contained therein) filed by the Company
covering  the Registrable Securities shall not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein, or
necessary to make the statements therein, in light of the circumstances in which
they  were  made,  not  misleading.  Except  in the event that Section (c) below
applies,  the Company shall: (i) prepare and file from time to time with the SEC
a  post-effective amendment to the Registration Statement or a supplement to the
related  Prospectus  or  a  supplement or amendment to any document incorporated
therein  by  reference  or  file  any  other  required  document  so  that  such


                                     I - 15
<PAGE>
Registration  Statement shall not contain an untrue statement of a material fact
or  omit  to state a material fact required to be stated therein or necessary to
make the statements therein not misleading, and so that, as thereafter delivered
to  the  Investor  of  the  Registrable  Securities  being sold thereunder, such
Prospectus  shall  not contain an untrue statement of a material fact or omit to
state  a  material  fact  required to be stated therein or necessary to make the
statements  therein,  in  light of the circumstances under which they were made,
not misleading; (ii) provide the Investor copies of any documents filed pursuant
to  Section  6.2(b)(i);  and  (iii)  inform  the  Investor  that the Company has
complied  with its obligations in Section 6.2(b)(i) (or that, if the Company has
filed a post-effective amendment to the Registration Statement which has not yet
been  declared  effective, the Company shall notify the Investor to that effect,
shall  use  its  commercially  reasonable efforts to secure the effectiveness of
such  post-effective amendment as promptly as possible and shall promptly notify
the  Investor pursuant to Section 6.2(b)(i) hereof when the amendment has become
effective).

          (b)     In  the  event:  (i)  of  any  request by the SEC or any other
federal  or  state  governmental authority during the period of effectiveness of
the  Registration  Statement  for  amendments  or  supplements to a Registration
Statement  or  a  related  Prospectus or for additional information; (ii) of the
issuance  by the SEC or any other federal or state governmental authority of any
stop  order  suspending  the  effectiveness  of  a Registration Statement or the
initiation  of  any  proceedings  for  that purpose; (iii) of the receipt by the
Company  of any notification with respect to the suspension of the qualification
or exemption from qualification of any of the Registrable Securities for sale in
any  jurisdiction  or the initiation of any proceeding for such purpose; or (iv)
of any event or circumstance which necessitates the making of any changes in the
Registration  Statement or Prospectus, or any document incorporated or deemed to
be  incorporated  therein by reference, so that, in the case of the Registration
Statement,  it  shall not contain any untrue statement of a material fact or any
omission  to state a material fact required to be stated therein or necessary to
make  the  statements  therein  not  misleading,  and  that  in  the case of the
Prospectus,  it shall not contain any untrue statement of a material fact or any
omission  to state a material fact required to be stated therein or necessary to
make  the statements therein, in the light of the circumstances under which they
were  made,  not  misleading;  then  the  Company shall deliver a certificate in
writing to the Investor (the "Suspension Notice") to the effect of the foregoing
and,  upon  receipt  of  such Suspension Notice, the Investor shall refrain from
selling  any  Registrable  Securities  pursuant to the Registration Statement (a
"Suspension")  until  the  Investor's  receipt  of  copies  of a supplemented or
amended  Prospectus prepared and filed by the Company, or until it is advised in
writing by the Company that the current Prospectus may be used, and has received
copies of any additional or supplemental filings that are incorporated or deemed
incorporated  by  reference  in  any  such  Prospectus.  In  the  event  of  any
Suspension,  the  Company shall use its commercially reasonable efforts to cause
the  use  of  the  Prospectus  so  suspended to be resumed as soon as reasonably
practicable after delivery of a Suspension Notice to the Investor, shall prepare
a  supplement  or amendment to the Registration Statement to correct such untrue
statement  or  omission, and shall deliver a number of copies of such supplement
or  amendment  to  the  Investor  as  the  Investor  may reasonably request.  In
addition  to  and  without  limiting  any  other  remedies  (including,  without
limitation,  at  law or at equity) available to the Investor, the Investor shall
be  entitled  to  specific  performance  in  the event that the Company fails to
comply  with  the  provisions  of this Section 6.2(b).  Subject to the Company's
rights  under  this  Section  6.2(b),  the  Company  shall  use its commercially
reasonable efforts to prevent the issuance of any stop order or other suspension
of  effectiveness  of  a Registration Statement and, if such an order is issued,
shall  use  its commercially reasonable efforts to obtain the withdrawal of such
order  at  the  earliest possible time and to notify the Investor that holds the
Registrable  Securities  being  sold  of  the  issuance  of  such  order and the
resolution  thereof.  If  the  use of the Registration Statement is suspended by
the  Company,  the  Company  shall promptly give notice of the suspension to the
Investor  and  shall  promptly  notify  the  Investor  as soon as the use of the
Registration  Statement  may  be  resumed.


                                     I - 16
<PAGE>
          (c)     Provided that a Suspension is not then in effect, the Investor
may  sell  the Registrable Securities under the Registration Statement, provided
that  it arranges for delivery of a current Prospectus to the transferee of such
Registrable  Securities.  Upon  receipt  of  a request therefor, the Company has
agreed to provide an adequate number of current Prospectuses to the Investor and
to  supply  copies  to  any  other  parties  requiring  such  Prospectuses.

     6.3     Review  by  the  Investor.  The Company shall permit the Investor's
             -------------------------
legal  counsel  to  review  the  Registration  Statement  and all amendments and
supplements  thereto  (as well as all requests for acceleration or effectiveness
thereof) for a reasonable period of time prior to their filing with the SEC, and
shall  not file any document in a form to which such counsel reasonably objects,
unless  otherwise  required by law in the opinion of the Company's counsel.  The
sections  of any such Registration Statement, including information with respect
to  the  Investor,  the  Investor'  beneficial  ownership  of  the  Registrable
Securities  or  the  Investor' intended method of disposition of the Registrable
Securities,  must  conform to the information provided to the Company by each of
the  Investor.

     6.4     Expenses.  Subject to the limitations contained herein, the Company
             --------
shall pay the following expenses incident to the registration of the Registrable
Securities  under  this Article VI: registration, filing and NASD fees, all fees
and  expenses  of  complying  with  state  securities or Blue Sky laws, all word
processing,  duplicating and printing expenses, messenger and delivery expenses,
the  fees  and  disbursements  of counsel for the Company and of its independent
public  accountants,  including  the  expenses  of  any  "cold  comfort" letters
required  by  or incident to such performance and compliance, premiums and other
costs  of  policies  of insurance purchased by the Company at its option against
liabilities  arising  out of the public offering of such Registrable Securities;
but  excluding  discounts,  spreads  and  commissions  and  fees and expenses of
selling  brokers,  dealer  managers or similar securities industry professionals
relating to the distribution of the Registrable Securities, transfer taxes, fees
and  disbursements  of  counsel  for  any  selling  shareholder(s),  fees  and
disbursements  of  the Company's public accountants for special audits and other
selling  expenses, if any, all of which expenses shall be borne by the Investor.

     6.5     Indemnification.
             ---------------

          (a)     For  the  purpose  of  this  Section  6.5:

               (i)     The term "Selling Stockholder" shall include the Investor
and  each  person,  if  any, who controls the Investor within the meaning of the
Securities  Act  or  any  affiliate  of  the  Investor;

               (ii)     The  term  "Registration  Statement"  shall  include any
final  Prospectus,  exhibit,  supplement or amendment included in or relating to
the  Registration  Statement  referred  to  in  Section  6.1;  and

               (iii)     The  term  "untrue  statement" shall include any untrue
statement  or  alleged  untrue statement, or any omission or alleged omission to
state  in  the  Registration  Statement  a  material  fact required to be stated
therein  or  necessary  to  make  the  statements  therein,  in the light of the
circumstances  under  which  they  were  made,  not  misleading.


                                     I - 17
<PAGE>
          (b)     The Company agrees to indemnify and hold harmless each Selling
Stockholder  from  and  against  any  losses,  claims,  damages,  liabilities or
expenses, joint or several, to which such Selling Stockholder may become subject
(under  the  Securities  Act,  the  Exchange  Act, or any other federal or state
statutory  law  or  regulation,  or  at  common  law  or otherwise (including in
settlement  of  any  litigation, if such settlement is effected with the written
consent  of  the  Company,  which  consent  shall not be unreasonably withheld),
insofar  as such losses, claims, damages, liabilities or expenses (or actions in
respect thereof as contemplated below) arise out of or are based upon any untrue
statement  of  any  material  fact  contained  in  the  Registration  Statement,
including  the  Prospectus,  financial  statements  and schedules, and all other
documents  filed  as  a part thereof, as amended at the time of effectiveness of
the  Registration  Statement,  including  any  information  deemed  to be a part
thereof  as of the time of effectiveness pursuant to paragraph (b) of Rule 430A,
or pursuant to Rule 434, of the Rules and Regulations, or the Prospectus, in the
form  first  filed  with the Commission pursuant to Rule 424(b) of the Rules and
Regulations,  or  filed  as  part  of  the Registration Statement at the time of
effectiveness  if  no  Rule 424(b) filing is required (the "Prospectus"), or any
amendment  or supplement thereto, or arise out of or are based upon the omission
or  alleged  omission  to  state  in  any of them a material fact required to be
stated  therein  or necessary to make the statements in any of them, in light of
the circumstances under which they were made, not misleading, or arise out of or
are  based  in  whole  or  in  part on any inaccuracy in the representations and
warranties  of  the  Company  contained in this Agreement, or any failure of the
Company  to perform its obligations under this Agreement or under law, and shall
reimburse  the Investor and each such controlling person for any legal and other
expenses  as  such  expenses  are  reasonably  incurred  by the Investor or such
controlling  person  in  connection  with  investigating,  defending,  settling,
compromising  or  paying  any  such  loss,  claim, damage, liability, expense or
action.  The Company shall reimburse such Selling Stockholder for any reasonable
legal  or  other  expenses  reasonably  incurred  in investigating, defending or
preparing  to  defend  any  such action, proceeding or claim, provided, however,
that  the  Company  shall not be liable in any such case to the extent that such
loss,  claim,  damage  or  liability  arises out of, or is based upon, an untrue
statement made in such Registration Statement in reliance upon and in conformity
with  written  information  furnished  to  the  Company  by or on behalf of such
Selling  Stockholder  specifically  for  use  in preparation of the Registration
Statement  or  the  failure  of  such  Selling  Stockholder  to  comply with its
covenants  and  agreements  contained  in Sections 3.1, 3.6 or 6.2 hereof or any
statement  or  omission  in  any  Prospectus that is corrected in any subsequent
Prospectus  that  was  delivered  to the Investor prior to the pertinent sale or
sales  by  the  Investor.

          (c)     The Investor agrees to indemnify and hold harmless the Company
(and each person, if any, who controls the Company within the meaning of Section
15 of the Securities Act, each officer of the Company who signs the Registration
Statement and each director of the Company) from and against any losses, claims,
damages  or  liabilities  to which the Company (or any such officer, director or
controlling  person) may become subject (under the Securities Act or otherwise),
insofar  as  such  losses,  claims,  damages  or  liabilities  (or  actions  or
proceedings in respect thereof) arise out of, or are based upon, (i) any failure
to  comply  with  the covenants and agreements contained in Sections 3.1, 3.6 or
6.2  hereof,  or  (ii)  any untrue statement of a material fact contained in the
Registration  Statement  but  only  to the extent that such untrue statement was
made in reliance upon and in conformity with written information furnished by or
on  behalf  of  the  Investor  specifically  for  use  in  preparation  of  the
Registration  Statement,  and  the Investor shall reimburse the Company (or such
officer,  director  or controlling person), as the case may be, for any legal or
other  expenses  reasonably incurred in investigating, defending or preparing to
defend  any  such  action,  proceeding  or  claim;  provided,  however, that the
Investor  shall  not  be liable for any such untrue statement which the Investor
has  delivered  to  the Company in writing a correction before the occurrence of
the  transaction  from  which  such  loss  was  incurred, and the Investor shall
reimburse  the  Company,  each of its directors, each of its officers who signed
the Registration Statement or controlling person for any legal and other expense
reasonably  incurred by the Company, each of its directors, each of its officers
who  signed  the Registration Statement or controlling person in connection with
investigating, defending, settling, compromising or paying any such loss, claim,
damage,  liability,  expense  or  action.


                                     I - 18
<PAGE>
          (d)     Promptly  after  receipt by any indemnified person of a notice
of a claim or the beginning of any action in respect of which indemnity is to be
sought  against  an  indemnifying  person  pursuant  to  this  Section 6.5, such
indemnified person shall notify the indemnifying person in writing of such claim
or  of  the  commencement  of  such  action,  but  the omission to so notify the
indemnifying  party shall not relieve it from any liability which it may have to
any  indemnified  party  under  this Section 6.5 (except to the extent that such
omission  materially  and  adversely affects the indemnifying party's ability to
defend such action) or from any liability otherwise than under this Section 6.5.
Subject  to  the provisions hereinafter stated, in case any such action shall be
brought against an indemnified person, the indemnifying person shall be entitled
to participate therein, and, to the extent that it shall elect by written notice
delivered to the indemnified party promptly after receiving the aforesaid notice
from  such  indemnified  party, shall be entitled to assume the defense thereof,
with  counsel  reasonably satisfactory to such indemnified person.  After notice
from  the  indemnifying  person  to  such  indemnified person of its election to
assume the defense thereof, such indemnifying person shall not be liable to such
indemnified  person  for  any  legal  expenses  subsequently  incurred  by  such
indemnified  person  in  connection with the defense thereof, provided, however,
that  if  there  exists or shall exist a conflict of interest that would make it
inappropriate,  in  the reasonable opinion of counsel to the indemnified person,
for  the  same  counsel  to  represent  both  the  indemnified  person  and such
indemnifying  person  or  any  affiliate  or  associate thereof, the indemnified
person  shall  be  entitled  to  retain  its  own counsel at the expense of such
indemnifying  person;  provided,  however,  that no indemnifying person shall be
responsible  for  the  fees  and  expenses  of  more  than  one separate counsel
(together  with  appropriate  local counsel) for all indemnified parties.  In no
event  shall any indemnifying person be liable in respect of any amounts paid in
settlement  of any action unless the indemnifying person shall have approved the
terms  of  such settlement; provided that such consent shall not be unreasonably
withheld.  No  indemnifying  person  shall, without the prior written consent of
the  indemnified  person,  effect  any  settlement  of any pending or threatened
proceeding  in  respect  of which any indemnified person is or could have been a
party  and  indemnification could have been sought hereunder by such indemnified
person,  unless  such  settlement  includes  an  unconditional  release  of such
indemnified  person  from all liability on claims that are the subject matter of
such  proceeding.  Notwithstanding  the  provisions  of  this  Section  6.5, the
Investor  shall  not  be  liable  for  any indemnification obligation under this
Agreement  in  excess  of  the amount of gross proceeds received by the Investor
from  the  sale  of  the  Registrable  Securities.

          (e)     If  the  indemnification  provided  for in this Section 6.5 is
unavailable  to  or  insufficient  to  hold  harmless an indemnified party under
subsection  (b)  or  (c)  above  in  respect  of  any losses, claims, damages or
liabilities  (or actions or proceedings in respect thereof) referred to therein,
then  each  indemnifying party shall contribute to the amount paid or payable by
such  indemnified  party  as  a  result  of  such  losses,  claims,  damages  or
liabilities (or actions in respect thereof) in such proportion as is appropriate
to  (i)  reflect  the relative benefits received by the Company and the Investor
from  the  placement of Common Stock or if the allocation provided by clause (i)
above  is  not permitted by applicable law, in such proportion as is appropriate
to  reflect  not  only the relative benefits referred to in clause (i) above but
the  relative  fault  of  the  Company  and  the Investor in connection with the
statements or omissions or inaccuracies in the representations and warranties in
this  Agreement  that  resulted  in such losses, claims, damages, liabilities or
expenses,  as  well  as  any  other  relevant  equitable  considerations.  The


                                     I - 19
<PAGE>
respective  relative  benefits  received  by the Company on the one hand and the
Investor on the other shall be deemed to be in the same proportion as the amount
paid  by  the  Investor  to  the  Company  pursuant  to  this  Agreement for the
Registrable  Securities purchased by the Investor that were sold pursuant to the
Registration  Statement  bears  to the difference (the "Difference") between the
amount  the Investor paid for the Registrable Securities that were sold pursuant
to  the Registration Statement and the amount received by the Investor from such
sale.  The  relative  fault  shall  be  determined  by reference to, among other
things,  whether  the  untrue  statement  or the omission or alleged omission to
state  a  mutual  fact or the inaccurate or alleged inaccurate representation or
warranty  relates  to information supplied by the Company on the one hand or the
Investor  on  the  other  and the parties' relative intent, knowledge, access to
information  and  opportunity  to correct or prevent such untrue statement.  The
provisions  set forth in Section 6.5 with respect to the notice of the threat or
commencement  of any threat or action shall apply if a claim for contribution is
to  be  made  under  this  Section; provided, however, that no additional notice
shall be required with respect to any threat or action for which notice has been
given  under  Section  6.5 for purposes of indemnification.  The Company and the
Investor  agree that it would not be just and equitable if contribution pursuant
to  this  subsection  (e)  were  determined  by pro rata allocation (even if the
Investor  were treated as one entity for such purpose) or by any other method of
allocation  which  does  not  take  into  account  the  equitable considerations
referred  to  above  in  this  subsection (e).  The amount paid or payable by an
indemnified  party as a result of the losses, claims, damages or liabilities (or
actions  in  respect  thereof) referred to above in this subsection (e) shall be
deemed to include, subject to the limitations set forth in this Section 6.5, any
legal  or  other  expenses  reasonably  incurred  by  such  indemnified party in
connection  with  investigating  or  defending  any  such  action  or  claim.
Notwithstanding  the  provisions  of  this  subsection (e), no Investor shall be
required  to  contribute  any  amount  in  excess  of  the  amount  by which the
Difference  exceeds  the  amount of any damages which the Investor has otherwise
been  required  to  pay  by reason of such untrue or alleged untrue statement or
omission  or alleged omission.  No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution  from  any  person  who  was  not  guilty  of  such  fraudulent
misrepresentation.  The  Investor'  obligations in this subsection to contribute
are  several in proportion to their sales of the Registrable Securities to which
such  loss  relates  and  not  joint.

          (f)     The parties to this Agreement hereby acknowledge that they are
sophisticated  business  persons  who  were  represented  by  counsel during the
negotiations  regarding the provisions hereof including, without limitation, the
provisions  of  this  Section  6.5,  and  are  fully  informed  regarding  said
provisions.  They  further  acknowledge  that the provisions of this Section 6.5
fairly  allocate the risks in light of the ability of the parties to investigate
the Company and its business in order to assure that adequate disclosure is made
in the Registration Statement as required by the Securities Act and the Exchange
Act.  The parties are advised that federal or state public policy as interpreted
by  the  courts  in  certain  jurisdictions  may  be  contrary to certain of the
provisions  of  this  Section 6.5, and the parties hereto hereby expressly waive
and relinquish any right or ability to assert such public policy as a defense to
a  claim  under  this Section 6.5 and further agree not to attempt to assert any
such  defense.

     6.6     Termination  of  Conditions  and  Obligations.  The  conditions
             ---------------------------------------------
precedent  imposed by Article III or this Article VI upon the transferability of
the Registrable Securities shall cease and terminate as to any particular number
of  the  Registrable  Securities  upon  the  passage  of  two (2) years from the
effective date of the Registration Statement or when such Registrable Securities
shall  have  been  effectively  registered  under the Securities Act and sold or
otherwise  disposed of in accordance with the intended method of disposition set
forth  in  the Registration Statement covering such Registrable Securities or at
such  time  as an opinion of counsel satisfactory to the Company shall have been
rendered to the effect that such conditions are not necessary in order to comply
with  the  Securities  Act.


                                     I - 20
<PAGE>
     6.7     Information  Available.  So  long  as the Registration Statement is
             ----------------------
effective  covering  the  resale  of  the  Registrable  Securities  owned by the
Investor,  the  Company  shall  furnish  to  the  Investor:

          (a)     as  soon as practicable after it is available (but in the case
of  the Company's Annual Report to Shareholders, within one hundred twenty (120)
days  after  the  end  of  each fiscal year of the Company), one copy of (i) its
Annual  Report  to  Stockholders  (which  Annual  Report shall contain financial
statements  audited  in accordance with generally accepted accounting principles
by  a  national  firm  of certified public accountants); (ii) if not included in
substance  in  the Annual Report to Stockholders, its Annual Report on Form 10-K
(the  foregoing,  in  each  case,  excluding exhibits); (iii) if not included in
substance  in  its  Quarterly  Reports to Shareholders, its quarterly reports on
Form  10-Q;  and  (iv)  a  full  copy  of  the particular Registration Statement
covering  the  Registrable  Securities  (the  foregoing, in each case, excluding
exhibits);

          (b)     upon  the  reasonable  request  of  the Investor, all exhibits
excluded  by  the parenthetical to subparagraphs (a)(ii), (iii) and (iv) of this
Section  6.7  as  filed  with  the  SEC  and  all other information that is made
available  to  shareholders;  and

          (c)     upon  the  reasonable  request  of  the  Investor, an adequate
number of copies of the Prospectuses to supply to any other party requiring such
Prospectuses;  and  the  Company,  upon  the reasonable request of the Investor,
shall  meet  with  the  Investor  or  a  representative thereof at the Company's
headquarters  to  discuss  all  information  relevant  for  disclosure  in  the
Registration  Statement  covering the Registrable Securities and shall otherwise
cooperate  with  any  Investor  conducting  an  investigation for the purpose of
reducing  or  eliminating  the  Investor's  exposure  to  liability  under  the
Securities  Act,  including  the  reasonable  production  of  information at the
Company's  headquarters;  provided,  that  the  Company shall not be required to
disclose  any  confidential  information to or meet at its headquarters with any
Investor until and unless the Investor shall have entered into a confidentiality
agreement  with the Company in form and substance reasonably satisfactory to the
Company  with  respect  thereto.

     6.8     Rule  144  Information.  In order to make available to the Investor
             ----------------------
the  benefits  of Rule 144 or any similar rule or regulation of the SEC that may
at any time permit the Investor to sell the Registrable Securities to the public
without  registration, the Company shall use its commercially reasonable efforts
to:

          (a)     file  with  the  SEC  in  a  timely  manner, and make and keep
available,  all  reports  and  other documents required of the Company under the
Securities  Act  and  the Exchange Act so long as the Company remains subject to
such  requirements (it being understood that nothing herein limits the Company's
obligations  under  Section  6.3  of  the Purchase Agreement) and the filing and
availability  of such reports and other documents is required for the applicable
provisions  of  Rule  144;  and

          (b)     furnish  to  the  Investor,  so long as the Investor holds the
Registrable  Securities,  promptly  upon  the  Investor's request, (i) a written
statement by the Company that it has complied with the reporting requirements of
Rule  144,  the  Securities  Act  and  the Exchange Act, (ii) a copy of the most
recent  annual  or  quarterly  report  of the Company and such other reports and
documents  filed by the Company with the SEC and (iii) such other information as
may  be  reasonably  requested  to  permit the Investor to sell such Registrable
Securities  pursuant  to  Rule  144  without  registration.


                                     I - 21
<PAGE>
     6.9     Assignment  of  Registration  Rights.  The  rights  of the Investor
             ------------------------------------
hereunder,  including  the  right  to  have the Company register the Registrable
Securities  pursuant  to  this Agreement, shall be automatically assigned by the
Investor  to  transferees or assignees of all or any portion of such Registrable
Securities,  but  only if (a) the Investor agrees in writing with the transferee
or  assignee to assign such rights, and a copy of such agreement is furnished to
the  Company within a reasonable time after such assignment, (b) the Company is,
within  a  reasonable  time  after  such  transfer or assignment, furnished with
written  notice  of  the name and address of such transferee or assignee and the
Registrable  Securities with respect to which such registration rights are being
transferred  or  assigned,  (c)  after  such transfer or assignment, the further
disposition  of  such  Registrable  Securities  by the transferee or assignee is
restricted under the Securities Act and applicable state securities laws, (d) at
or  before  the  time  the  Company  received the written notice contemplated by
clause  (b)  of this sentence, the transferee or assignee agrees in writing with
the  Company  to be bound by all of the provisions contained herein, and (e) the
transferee  is  an  "accredited investor" as that term is defined in Rule 501 of
Regulation  D.

                                   ARTICLE VII
                 TRANSFER AGENT INSTRUCTIONS; REMOVAL OF LEGENDS

     7.1     Issuance  of  Registrable  Securities.  The Company shall issue the
             -------------------------------------
Warrants and shall instruct its transfer agent to issue certificates, registered
in  the  name of the Investor or its nominee, for the Shares and, when issued in
accordance with the terms of the Warrants, the Warrant Shares and the Additional
Warrant  Shares.  The  Warrants  and  all  such  certificates  shall  bear  the
restrictive  legend  described  in Section 3.7, except as otherwise specified in
this  Article  VII.  The  Company  shall  not  give  to  its  transfer agent any
instruction  other  than  as  described  in  this  Article VII and stop-transfer
instructions  to give effect to Section 3.7 hereof (prior to registration of the
Registrable Securities under the Securities Act).  Nothing in this Section shall
affect in any way the Investor's obligations and agreement set forth in Sections
3.6 and 3.7 hereof to resell the Registrable Securities pursuant to an effective
registration  statement or in compliance with an exemption from the registration
requirement  of  applicable  securities  laws.

     7.2     Unrestricted Registrable Securities.  If, unless otherwise required
             -----------------------------------
by applicable state securities laws, (a) Registrable Securities represented by a
certificate have been registered under an effective registration statement filed
under  the  Securities  Act, (b) a holder of the Registrable Securities provides
the  Company  and  the  Transfer  Agent  with  an  opinion  of counsel, in form,
substance  and  scope  customary  for  opinions  of  counsel  in  comparable
transactions,  to  the effect that a public sale or transfer of such Registrable
Securities  may  be  made without registration under the Securities Act and such
sale  either has occurred or may occur without restriction on the manner of such
sale  or  transfer,  (c) such holder provides the Company and the Transfer Agent
with  reasonable  assurances  that such Registrable Securities can be sold under
Rule  144, or (d) such Registrable Securities can be sold without restriction as
to  the number of the Registrable Securities sold under Rule 144(k), the Company
shall permit the transfer of such Registrable Securities, and the Transfer Agent
shall  issue one or more certificates, free from any restrictive legend, in such
name  and  in such denominations as specified by such holder.  In the event that
the  restrictive  legend  is  removed  from  any  of  the  certificates for such
Registrable  Securities  and  thereafter  the  effectiveness  of  a registration
statement covering such Registrable Securities is suspended or terminated or the
Company  determines  that  a  supplement  or  amendment  thereto  is required by
applicable  securities  laws,  then  upon  a  reasonable  advance  notice to the
Investor  the  Company  may require that the restrictive legend be placed on any
certificates  for such Registrable Securities that cannot be sold pursuant to an
effective  registration  statement  or  under  Rule  144, and the Investor shall
cooperate  in  the  replacement of such legend.  Such legend shall thereafter be
removed  when  such  Registrable  Securities  may  again  be sold pursuant to an
effective  registration  statement  or  Rule  144.


                                     I - 22
<PAGE>
                                  ARTICLE VIII
                 CONDITIONS TO THE COMPANY'S OBLIGATION TO SELL

     The obligation of the Company to issue and sell the Shares and the Warrants
to  the  Investor at the Closing is subject to the satisfaction by the Investor,
on  or  before  the Closing Date, of the following conditions.  These conditions
are  for the Company's sole benefit and may be waived by the Company at any time
in  its  sole  discretion:

     8.1     Shareholder  Approval  shall  have  been  obtained.

     8.2     The Investor shall have delivered the Purchase Price to the Company
in  accordance  with  this  Agreement.

     8.3     The  representations  and  warranties of the Investor shall be true
and  correct  in  all material respects as of the Closing Date as though made on
such date (except for representations and warranties that speak as of a specific
date, which representations and warranties must be correct as of such date), and
the Investor shall have performed and complied in all material respects with the
covenants  and conditions required by this Agreement to be performed or complied
with  by  the  Investor  at  or  prior  to  the Closing.  The Company shall have
received a certificate or certificates dated as of the Closing Date and executed
by  the  Investor  or a duly authorized officer of the Investor certifying as to
the  matters  contained  in  this  Section  8.3.

     8.4     No  statute,  rule,  regulation, executive order, decree, ruling or
injunction  shall  have  been enacted, entered, promulgated or endorsed by or in
any  court  or  governmental  authority  of  competent  jurisdiction  or  any
self-regulatory  organization  having  authority  over  the matters contemplated
hereby  which prohibits the consummation of any of the transactions contemplated
by  this  Agreement.

                                   ARTICLE IX
               CONDITIONS TO THE INVESTOR'S OBLIGATION TO PURCHASE

     The  obligation  of  the  Investor hereunder to purchase the Shares and the
Warrants  from  the Company at the Closing is subject to the satisfaction, on or
before  the Closing Date, of the following conditions.  These conditions are for
the Investor's benefit and may be waived by the Investor at any time in its sole
discretion:

     9.1     Shareholder  Approval  shall  have  been  obtained.

     9.2     The  Company  shall  have  delivered  to the Investor duly executed
certificates  representing  the Shares and the duly executed Initial Warrant and
Second  Warrant.

     9.3     The representations and warranties of the Company shall be true and
correct  in  all material respects as of the Closing Date as though made on such
date  (except  for  representations  and  warranties that speak as of a specific
date,  which  representations and warranties must be true and correct as of such


                                     I - 23
<PAGE>
date)  and the Company must have performed and complied in all material respects
with  the covenants and conditions required by this Agreement to be performed or
complied  with  by  the  Company at or prior to the Closing.  The Investor shall
have  received  a  certificate  or certificates dated as of the Closing Date and
executed  by  the  Chief Executive Officer or the Chief Financial Officer of the
Company  certifying  as  to  the matters contained in this Section 9.3 and as to
such  other  matters  as may be reasonably requested by the Investor, including,
but  not  limited  to,  the  Company's Certificate of Incorporation, as amended,
By-laws,  as  amended,  Board  of  Directors'  resolutions  relating  to  the
transactions  contemplated  hereby  and the incumbency and signatures of each of
the  officers  of  the  Company  who  may  execute  on behalf of the Company any
document  delivered  at  the  Closing.

     9.4     No  litigation, statute, rule, regulation, executive order, decree,
ruling  or injunction shall have been enacted, entered, promulgated, endorsed or
threatened  by  or  in  any  court  or  governmental  authority  of  competent
jurisdiction  or  any  self-regulatory  organization  having  authority over the
matters  contemplated  hereby  which  prohibits  or  seeks  to  prohibit  the
consummation  of  any  of  the  transactions  contemplated  by  this  Agreement.

     9.5     Trading  and  listing  of the Common Stock on Nasdaq shall not have
been  suspended  or  materially  limited  by  the  SEC  or  Nasdaq.

     9.6     The Investor shall have received an opinion letter of the Company's
counsel,  Pepper  Hamilton LLP, dated as of the Closing Date, in form, scope and
substance  reasonably  satisfactory  to  the Investor and containing opinions in
substantially  the  form  attached  hereto  as  Exhibit  F.
                                                ----------

     9.7     The  Company  shall have delivered evidence reasonably satisfactory
to  the  Investor  that  the  Company's  transfer  agent  has  agreed  to act in
accordance  with irrevocable instructions in the form attached hereto as Exhibit
                                                                         -------
G.
-

                                    ARTICLE X
                                   DEFINITIONS

     10.1     "Closing"  means  the  closing  of  the  purchase  and sale of the
Securities  (other  than  the  Note)  under  this  Agreement.

     10.2     "Closing  Date"  has  the  meaning  set  forth  in  Section  2.3.

     10.3     "Common  Stock"  means the common stock, $.01 par value per share,
     of the Company.

     10.4     "Company"  means  DA  Consulting Group, Inc., a Texas corporation.

     10.5     "Exchange  Act"  means  the  Securities  Exchange  Act of 1934, as
     amended.

     10.6     "Investor"  means  the  investor  whose  name  is set forth on the
signature  pages  of  this  Agreement.

     10.7     "Market  Price Per Share" means the average of the last sale price
for the Common Stock as quoted on the NASDAQ National Market System for the five
(5) trading days ending on the second trading day prior to the date on which the
Warrants  are  exercised  (from  time  to time as the case may be) or, if not so
quoted, means the price as mutually agreed upon by the parties or if the parties
can not so mutually agree, the price determined by a neutral party appraiser, as
chosen  by  the  Investor  and  reasonably  agreed  to  by  the  Company.


                                     I - 24
<PAGE>
     10.8     "Material  Adverse  Effect" means a material adverse effect on the
business,  operations,  assets  or  financial  condition  of  the  Company  on a
consolidated  basis.

     10.9     "Nasdaq"  means  the  Nasdaq  National  Market  System.

     10.10    "Registrable  Securities  has the meaning set forth in Article VI.

     10.11    "Regulation  D" means Regulation D as promulgated by the SEC under
     the  Securities  Act.

     10.12    "Rule  144"  and  "Rule  144(k)"  mean  Rule  144 and Rule 144(k),
     respectively,  promulgated under the Securities Act, or any successor rule.

     10.13    "SEC" means the United States Securities and Exchange Commission.

     10.14    "SEC  Documents"  has  the  meaning  set  forth  in  Section  4.6.

     10.15     "Securities  Act"  means  the Securities Act of 1933, as amended,
     and the rules and regulations thereunder, or any similar successor statute.

     10.16    "Shareholder Approval" has the meaning set forth in Section 5.12.


                                   ARTICLE XI
                          GOVERNING LAW; MISCELLANEOUS

     11.1     Governing  Law; Jurisdiction.  This Agreement shall be governed by
              ----------------------------
and  interpreted  in  accordance  with the laws of the State of New York without
regard  to the principles of conflict of laws.  The parties hereto hereby submit
to  the  exclusive  jurisdiction  of  the United States federal and state courts
located  in the State of New York with respect to any dispute arising under this
Agreement,  the  agreements  entered  into  in  connection  herewith  or  the
transactions  contemplated  hereby.

     11.2     Counterparts;  Signatures  by  Facsimile.  This  Agreement  may be
              ----------------------------------------
executed  in  two  or more counterparts, all of which are considered one and the
same  agreement and shall become effective when counterparts have been signed by
each party and delivered to the other parties.  This Agreement, once executed by
a  party, may be delivered to the other parties hereto by facsimile transmission
of  a  copy  of  this Agreement bearing the signature of the party so delivering
this  Agreement.  In  the  event  any  signature  is  delivered  by  facsimile
transmission,  the  party  using such means of delivery shall cause the manually
executed  pages  to  be  physically  delivered  to the other parties within five
business  days  of  the  execution  hereof.

     11.3     Headings.  The  headings  of this Agreement are for convenience of
              --------
reference  only,  are  not  part  of  this  Agreement  and  do  not  affect  its
interpretation.

     11.4     Severability.  If  any  provision  of this Agreement is invalid or
              ------------
unenforceable  under  any applicable statute or rule of law, then such provision
shall  be  deemed modified in order to conform with such statute or rule of law.
Any provision hereof that may prove invalid or unenforceable under any law shall
not  affect  the  validity  or  enforceability  of  any  other provision hereof.


                                     I - 25
<PAGE>
     11.5     Entire  Agreement;  Amendments.  This  Agreement  (including  all
              ------------------------------
schedules  and exhibits hereto), the Note and the Warrants constitute the entire
agreement  among  the  parties hereto with respect to the subject matter hereof.
There  are  no  restrictions,  promises,  warranties or undertakings, other than
those  set  forth  or  referred  to  herein.  This  Agreement,  the Note and the
Warrants  supersede  all  prior  agreements and understandings among the parties
hereto  with  respect  to  the  subject  matter  hereof.  No  provision  of this
Agreement may be waived or amended other than by an instrument in writing signed
by  the  party  to  be  charged  with  enforcement.

     11.6     Notices.  Any  notices required or permitted to be given under the
              -------
terms  of  this  Agreement  must be sent by certified or registered mail (return
receipt requested) or delivered personally or by courier (including a recognized
overnight delivery service) or by facsimile and shall be effective five (5) days
after being placed in the mail, if mailed by regular U.S. mail, or upon receipt,
if  delivered  personally, by courier (including a recognized overnight delivery
service)  or by facsimile, in each case addressed to a party.  The addresses for
such  communications  are:

     If to the Company:    DA  Consulting  Group,  Inc.
                           San  Felipe  Plaza
                           5847  San  Felipe,  Suite  37000
                           Houston,  Texas  77057
                           Attention: John E. Mitchell, Chief Executive Officer;
                           and Dennis C. Fairchild, Chief  Financial  Officer
                           Facsimile:  713-361-3001

     With a copy  to:      Pepper  Hamilton  LLP
                           3000  Two  Logan  Square
                           Philadelphia,  Pennsylvania  19103
                           Attention:  Barry  M.  Abelson,  Esquire

     If  to  the  Investor:  To  the  addresses  set forth immediately below the
Investor's  name  on  its  signature  page  hereto.

     Each party shall provide written notice to the other party of any change in
its address.

     11.7     Successors and Assigns.  This Agreement is binding upon and inures
              ----------------------
to  the  benefit  of  the parties and their successors and assigns.  The Company
shall  not  assign this Agreement or any rights or obligations hereunder without
the  prior written consent of the Investor, and the Investor may not assign this
Agreement  or  any  rights  or  obligations  hereunder without the prior written
consent  of the Company.  Notwithstanding the foregoing, the Investor may assign
all  or part of its rights and obligations hereunder to any of its "affiliates,"
as  that  term  is  defined under the Securities Act, without the consent of the
Company so long as the affiliate is an "accredited investor" (within the meaning
of  Regulation  D under the Securities Act) and agrees in writing to be bound by
this  Agreement.

     11.8     Third-Party  Beneficiaries.  This  Agreement  is  intended for the
              --------------------------
benefit  of  the  parties  hereto  and their respective permitted successors and
assigns, and is not for the benefit of, nor may any provision hereof be enforced
by,  any  other  person.

     11.9     Survival.  The  representations  and warranties of the Company and
              --------
the  agreements  and  covenants  set  forth  herein  shall  survive  the Closing
hereunder  and  remain in full force and effect regardless of any investigations
heretofore or hereafter made by or on behalf of either of the parties hereto for
the  period  time  commencing  on  the  date  hereof  and  ending  on  the third
anniversary of the Closing Date, unless Shareholder Approval is not obtained, in
which  case,  ending on the date the Note is paid in full.  The Company makes no
representations  or  warranties  in  any oral or written information provided to
Investor,  other  than  the  representations  and  warranties  included  herein.


                                     I - 26
<PAGE>
     11.10     Further Assurances.  Each party shall do and perform, or cause to
               ------------------
be  done  and performed, all such further acts and things, and shall execute and
deliver  all  other  agreements,  certificates,  instruments  and  documents, as
another  party  may  reasonably  request  in  order  to carry out the intent and
accomplish  the  purposes  of  this  Agreement  and  the  consummation  of  the
transactions  contemplated  hereby.

     11.11     No  Strict  Construction.  The language used in this Agreement is
               ------------------------
deemed  to be the language chosen by the parties to express their mutual intent,
and  no  rules  of  strict  construction  shall  be  applied  against any party.

     11.12     Equitable Relief.  Each party acknowledges that a breach by it or
               ----------------
its  obligations  hereunder  will cause irreparable harm to the other parties by
vitiating  the  intent  and  purposes  of  the transactions contemplated hereby.
Accordingly,  each party acknowledges that the remedy at law for a breach of its
obligations  hereunder  will be inadequate and agrees, in the event of a breach,
actual  or  threatened,  by such party of the provisions of this Agreement, that
the  other party shall be entitled, in addition to all other available remedies,
to  temporary  and  permanent  injunctive  relief  in  any such case without the
necessity  of  proving  actual  damages.


                                     I - 27
<PAGE>
     IN WITNESS WHEREOF, the Company and the Investor have caused this Agreement
to  be  duly  executed  as  of  the  date  first  above  written.

                                        COMPANY:

                                        DA  CONSULTING  GROUP,  INC.



                                        By:  /s/  John  E.  Mitchell
                                           -------------------------------------
                                           Name:  John  E.  Mitchell
                                           Title:  President  and  CEO

                                        INVESTOR:

                                        PURSE  HOLDING  LIMITED,
                                        a British Virgin Islands limited company

                                        By:  /s/  B.K.  Prasad
                                           -------------------------------------
                                           Name:  B.  K.  Prasad
                                           Title:  Authorized  Signatory

                                        Address:  Altstetterstrasse  126
                                                  P.O.  Box  1705
                                                  CH  -  8048
                                                  Zurich,  Switzerland
                                        Attention:  Fredy  Eckstein
                                        Facsimile:  +41-1-439  6266

                                        with  copies  of  all  notices  to:

                                        Morrison  &  Foerster  LLP
                                        1290  Avenue  of  the  Americas
                                        New  York,  New  York  10104
                                        Attention:  Joseph  Bartlett,  Esq.
                                        Facsimile:  (212)  468-7900


                                     I - 28
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission